BRIEF-Acelrx Pharmaceuticals says start date for IAP312 study revised
July 08, 2016 at 06:15 AM EDT
* Acelrx Pharmaceuticals Inc says has finalized certain modifications to the Zalviso device and pending receipt of the devices from the manufacturer
